Rapid Test Market (Type: Laboratory Rapid Test and Over-the-counter/Home-use Rapid Test; and Technology: Immunoassay, Chromatography, Spectroscopy, PCR, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Rapid Test Market (Type: Laboratory Rapid Test and Over-the-counter/Home-use Rapid Test; and Technology: Immunoassay, Chromatography, Spectroscopy, PCR, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Rapid Test Market – Scope of Report

TMR’s report on the global rapid test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global rapid test market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global rapid test market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the rapid test market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global rapid test market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global rapid test market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global rapid test market.

The report delves into the competitive landscape of the global rapid test market. Key players operating in the global rapid test market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global rapid test market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market rapid test.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Rapid Test Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Rapid Test Market Analysis and Forecasts, 2017 - 2031
5. Key Insights
5.1. Top Players Operating in the Market Space
5.2. Disease Prevalence & Incidence Rate, Globally with Key Countries
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Rapid Test Market Analysis and Forecasts, By Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Type, 2017 - 2031
6.3.1. Laboratory Rapid Test
6.3.2. Over-the-counter/Home-use Rapid Test
6.4. Market Attractiveness By Type
7. Global Rapid Test Market Analysis and Forecasts, By Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Technology, 2017 - 2031
7.3.1. Immunoassay
7.3.2. Chromatography
7.3.3. Spectroscopy
7.3.4. PCR
7.3.5. Others
7.4. Market Attractiveness By Technology
8. Global Rapid Test Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By Application, 2017 - 2031
8.3.1. COVID-19 Test
8.3.2. Infectious Disease
8.3.2.1. Influenza
8.3.2.2. Malaria
8.3.2.3. Dengue
8.3.2.4. HIV
8.3.2.5. Others
8.3.3. Glucose Test
8.3.4. Pregnancy Test
8.3.5. Cholesterol Test
8.3.6. Others
8.4. Market Attractiveness By Application
9. Global Rapid Test Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast By End-user, 2017 - 2031
9.3.1. Hospitals
9.3.2. Home Care
9.3.3. Diagnostic Centers
9.3.4. Others
9.4. Market Attractiveness By End-user
10. Global Rapid Test Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Rapid Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2017 - 2031
11.2.1. Laboratory Rapid Test
11.2.2. Over-the-counter/Home-use Rapid Test
11.3. Market Value Forecast By Technology, 2017 - 2031
11.3.1. Immunoassay
11.3.2. Chromatography
11.3.3. Spectroscopy
11.3.4. PCR
11.3.5. Others
11.4. Market Value Forecast By Application, 2017 - 2031
11.4.1. COVID-19 Test
11.4.2. Infectious Disease
11.4.2.1. Influenza
11.4.2.2. Malaria
11.4.2.3. Dengue
11.4.2.4. HIV
11.4.2.5. Others
11.4.3. Glucose Test
11.4.4. Pregnancy Test
11.4.5. Cholesterol Test
11.4.6. Others
11.5. Market Value Forecast By End-user, 2017 - 2031
11.5.1. Hospitals
11.5.2. Home Care
11.5.3. Diagnostic Centers
11.5.4. Others
11.6. Market Value Forecast By Country, 2017 - 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Technology
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Rapid Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2017 - 2031
12.2.1. Laboratory Rapid Test
12.2.2. Over-the-counter/Home-use Rapid Test
12.3. Market Value Forecast By Technology, 2017 - 2031
12.3.1. Immunoassay
12.3.2. Chromatography
12.3.3. Spectroscopy
12.3.4. PCR
12.3.5. Others
12.4. Market Value Forecast By Application, 2017 - 2031
12.4.1. COVID-19 Test
12.4.2. Infectious Disease
12.4.2.1. Influenza
12.4.2.2. Malaria
12.4.2.3. Dengue
12.4.2.4. HIV
12.4.2.5. Others
12.4.3. Glucose Test
12.4.4. Pregnancy Test
12.4.5. Cholesterol Test
12.4.6. Others
12.5. Market Value Forecast By End-user, 2017 - 2031
12.5.1. Hospitals
12.5.2. Home Care
12.5.3. Diagnostic Centers
12.5.4. Others
12.6. Market Value Forecast By Country, 2017 - 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Technology
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Rapid Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2017 - 2031
13.2.1. Laboratory Rapid Test
13.2.2. Over-the-counter/Home-use Rapid Test
13.3. Market Value Forecast By Technology, 2017 - 2031
13.3.1. Immunoassay
13.3.2. Chromatography
13.3.3. Spectroscopy
13.3.4. PCR
13.3.5. Others
13.4. Market Value Forecast By Application, 2017 - 2031
13.4.1. COVID-19 Test
13.4.2. Infectious Disease
13.4.2.1. Influenza
13.4.2.2. Malaria
13.4.2.3. Dengue
13.4.2.4. HIV
13.4.2.5. Others
13.4.3. Glucose Test
13.4.4. Pregnancy Test
13.4.5. Cholesterol Test
13.4.6. Others
13.5. Market Value Forecast By End-user, 2017 - 2031
13.5.1. Hospitals
13.5.2. Home Care
13.5.3. Diagnostic Centers
13.5.4. Others
13.6. Market Value Forecast By Country, 2017 - 2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Technology
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Latin America Rapid Test Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2017 - 2031
14.2.1. Laboratory Rapid Test
14.2.2. Over-the-counter/Home-use Rapid Test
14.3. Market Value Forecast By Technology, 2017 - 2031
14.3.1. Immunoassay
14.3.2. Chromatography
14.3.3. Spectroscopy
14.3.4. PCR
14.3.5. Others
14.4. Market Value Forecast By Application, 2017 - 2031
14.4.1. COVID-19 Test
14.4.2. Infectious Disease
14.4.2.1. Influenza
14.4.2.2. Malaria
14.4.2.3. Dengue
14.4.2.4. HIV
14.4.2.5. Others
14.4.3. Glucose Test
14.4.4. Pregnancy Test
14.4.5. Cholesterol Test
14.4.6. Others
14.5. Market Value Forecast By End-user, 2017 - 2031
14.5.1. Hospitals
14.5.2. Home Care
14.5.3. Diagnostic Centers
14.5.4. Others
14.6. Market Value Forecast By Country, 2017 - 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Technology
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Rapid Test Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Type, 2017 - 2031
15.2.1. Laboratory Rapid Test
15.2.2. Over-the-counter/Home-use Rapid Test
15.3. Market Value Forecast By Technology, 2017 - 2031
15.3.1. Immunoassay
15.3.2. Chromatography
15.3.3. Spectroscopy
15.3.4. PCR
15.3.5. Others
15.4. Market Value Forecast By Application, 2017 - 2031
15.4.1. COVID-19 Test
15.4.2. Infectious Disease
15.4.2.1. Influenza
15.4.2.2. Malaria
15.4.2.3. Dengue
15.4.2.4. HIV
15.4.2.5. Others
15.4.3. Glucose Test
15.4.4. Pregnancy Test
15.4.5. Cholesterol Test
15.4.6. Others
15.5. Market Value Forecast By End-user, 2017 - 2031
15.5.1. Hospitals
15.5.2. Home Care
15.5.3. Diagnostic Centers
15.5.4. Others
15.6. Market Value Forecast By Country, 2017 - 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Technology
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2021)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. Hologic, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. Becton, Dickinson and Company
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. F. Hoffmann-La Roche Ltd.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Danaher Corporation
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Thermo Fisher Scientific, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Bio-Rad Laboratories, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. PerkinElmer, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Quidel Corporation
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. Meridian Bioscience Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
16.3.11. Elabscience Biotechnology Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview
16.3.12. OraSure Technologies
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. SWOT Analysis
16.3.12.4. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings